Cardiomyopathies are diseases of the heart muscle, a term introduced in 1957 to identify a
group of myocardial diseases not attributable to coronary artery disease. The definition has since been
modified to refer to structural and or functional abnormalities of the myocardium where other known
causes of myocardial dysfunction, such as systemic hypertension, valvular disease and ischemic heart
disease, have been excluded. In this review, we discuss the pathophysiology, clinical assessment and
therapeutic strategies for hypertrophic, dilated and hypertrophic cardiomyopathies, with a particular focus on aspects
unique to children.